WASHINGTON, DC (April 2, 2019) — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit, today released a report showcasing its impact on the rapidly advancing field of lung cancer research and patient care. The report demonstrates the impact of LUNGevity on improving outcomes for lung cancer patients through a better understanding of diagnosis, treatment, and quality of life as well as through driving research and policy reforms. More people are now living well with lung cancer than ever before.
The report shows the advancements in the Foundation’s research program, patient services, major initiatives, fundraising achievements, marketing reach, and more, and how these accomplishments help drive progress in all areas of the lung cancer field. Issuing this report celebrates breakthroughs in the field of lung cancer while encouraging people to join the organization to fund impactful research, advocate for change, create tools and resources for support and education, and fundraise for progress.
“We hope that seeing the impact that patient advocacy can have on the lung cancer patient community will inspire others to see the difference they can make, too,” Andrea Ferris, President and CEO of LUNGevity, said. “As the nation’s largest and most trusted lung cancer nonprofit, we encourage others to join us in our work. I’m proud of the work that LUNGevity is doing to improve outcomes for people diagnosed with lung cancer and I applaud all on our team, and all of our constituents, who are making change happen. We have the greatest impact when we work together.”
LUNGevity is dedicated to fostering an increasingly active lung cancer community—more empowered patients, more long-term survivors, and more living well with lung cancer.
About LUNGevity Foundation
LUNGevity is the nation's leading lung cancer organization investing in lifesaving, translational research and providing support services and education for patients and caregivers. LUNGevity’s goals are three-fold: (1) accelerate research to patients, (2) empower patients to be active participants in their treatment decisions, and (3) remove barriers that patients face in accessing the right treatments.
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. LUNGevity’s comprehensive resources include a medically vetted website with the latest information on all aspects of the disease, a toll-free HELPLine in partnership with CancerCare®, a unique Lung Cancer Navigator app, peer-to-peer mentoring for patients and caregivers (LUNGevity LifeLine), and survivorship conferences. LUNGevity also helps patients find and navigate clinical trials through our Clinical Trial Finder tool, a Clinical Trial Ambassador program, and participation with EmergingMed.
Our vision is a world where no one dies of lung cancer. For more information about LUNGevity Foundation, a four-star Charity Navigator organization, please visit www.LUNGevity.org.
About Lung Cancer in the U.S.
- About 1 in 16 Americans will be diagnosed with lung cancer in their lifetime
- More than 234,000 people in the U.S. will be diagnosed with lung cancer this year
- About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
- Lung cancer takes more lives than the next three leading cancers (colorectal, breast, and prostate) combined
- Only 19% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it’s caught before it spreads, the chance of 5-year survival improves dramatically